Legal Representation
Attorney
Steven R. Sumsion
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 1, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Mar 31, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 16, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 16, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 16, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 5, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 17, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Chemotherapeutics; Liquid nutritional supplement
First Use Anywhere:
Jun 25, 2019
First Use in Commerce:
Jun 25, 2019
Additional Information
Pseudo Mark
GENE NANOTECH
Classification
International Classes
005